Bioxytran (BIXT) Gross Profit (2010 - 2018)
Bioxytran's Gross Profit was $12,195 in Q2 2018, down 39.3% from $20,076 a year earlier.
Powered by 
Analysis
Bioxytran (BIXT) Gross Profit (2010 - 2018) Analysis & Trends
On a trailing twelve-month basis, Bioxytran's Gross Profit was $83,757 through Jun 30, 2018, down 25.6% year-over-year; for FY2017, it came in at $87,098, down 42.0% from FY2016.
- Gross Profit shows a five-year compound annual growth rate of -14.5% (FY2012 to FY2017).
- In earlier years, Gross Profit was $150,191 in FY2016 (+25.0%), $120,137 in FY2015 (+9.6%), $109,639 in FY2014 (-50.2%) and $219,945 in FY2013 (+15.2%).
- Quarterly Gross Profit has moved between -$77,551 (Q4 2014) and $154,158 (Q1 2014) over five years.
- Compared with a year earlier, Gross Profit was higher in two of the last four quarters, with an average decline of 2.8%.
- The best year-over-year quarter for Gross Profit over five years was Q3 2015 (growth of 498.0%); the worst was Q1 2016 (a decline of 69.3%).
- Per Business Quant data, BIXT's Gross Profit in the three quarters before Q2 2018 was -$1,933 (Q1 2018), -$6,595 (Q4 2017) and $80,090 (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 12,195.00 |
| Mar 31, 2018 | -1,933.00 |
| Dec 31, 2017 | -6,595.00 |
| Sep 30, 2017 | 80,090.00 |
| Jun 30, 2017 | 20,076.00 |
| Mar 31, 2017 | -6,237.00 |
| Dec 31, 2016 | 35,731.00 |
| Sep 30, 2016 | 62,940.00 |
| Jun 30, 2016 | 36,801.00 |
| Mar 31, 2016 | 14,719.00 |
| Dec 31, 2015 | -4,802.00 |
| Sep 30, 2015 | 42,988.00 |
| Jun 30, 2015 | 44,676.00 |
| Mar 31, 2015 | 47,942.00 |
| Dec 31, 2014 | -77,551.00 |
| Sep 30, 2014 | 7,189.00 |
| Jun 30, 2014 | 25,843.00 |
| Mar 31, 2014 | 154,158.00 |
| Dec 31, 2013 | 69,189.00 |
| Sep 30, 2013 | 14,512.00 |
API Access
Bioxytran Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();